PMC:7247521 / 985-1378 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"29","span":{"begin":163,"end":169},"obj":"Gene"},{"id":"30","span":{"begin":180,"end":184},"obj":"Gene"},{"id":"31","span":{"begin":271,"end":275},"obj":"Gene"},{"id":"40","span":{"begin":57,"end":69},"obj":"Disease"},{"id":"41","span":{"begin":79,"end":100},"obj":"Disease"},{"id":"42","span":{"begin":102,"end":108},"obj":"Disease"},{"id":"43","span":{"begin":110,"end":147},"obj":"Disease"},{"id":"44","span":{"begin":257,"end":266},"obj":"Disease"}],"attributes":[{"id":"A29","pred":"tao:has_database_id","subj":"29","obj":"Gene:406959"},{"id":"A30","pred":"tao:has_database_id","subj":"30","obj":"Gene:1022"},{"id":"A31","pred":"tao:has_database_id","subj":"31","obj":"Gene:59272"},{"id":"A40","pred":"tao:has_database_id","subj":"40","obj":"MESH:D003141"},{"id":"A41","pred":"tao:has_database_id","subj":"41","obj":"MESH:D007249"},{"id":"A42","pred":"tao:has_database_id","subj":"42","obj":"MESH:D001249"},{"id":"A43","pred":"tao:has_database_id","subj":"43","obj":"MESH:D029424"},{"id":"A44","pred":"tao:has_database_id","subj":"44","obj":"MESH:D011014"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"gnaling pathway, adipocytokine signaling pathway, etc.), TTD diseases (chronic inflammatory diseases, asthma, chronic obstructive pulmonary Disease, etc.), miRNA (MIR183), kinase (CDK7) and TF (LXR). QFPD contained 257 specific targets in addition to HCoV, pneumonia and ACE2 co-expression proteins. Then, network topology analysis of the five components-target-pathway-disease networks yielde"}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T23","span":{"begin":130,"end":139},"obj":"UBERON:0002048"},{"id":"T24","span":{"begin":156,"end":161},"obj":"SO:0000276"},{"id":"T25","span":{"begin":180,"end":184},"obj":"PR:000005265"},{"id":"T26","span":{"begin":271,"end":275},"obj":"G_3;PG_10;PR:000003622"},{"id":"T27","span":{"begin":279,"end":289},"obj":"GO:0010467"}],"text":"gnaling pathway, adipocytokine signaling pathway, etc.), TTD diseases (chronic inflammatory diseases, asthma, chronic obstructive pulmonary Disease, etc.), miRNA (MIR183), kinase (CDK7) and TF (LXR). QFPD contained 257 specific targets in addition to HCoV, pneumonia and ACE2 co-expression proteins. Then, network topology analysis of the five components-target-pathway-disease networks yielde"}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T2","span":{"begin":290,"end":298},"obj":"Body_part"}],"attributes":[{"id":"A2","pred":"fma_id","subj":"T2","obj":"http://purl.org/sig/ont/fma/fma67257"}],"text":"gnaling pathway, adipocytokine signaling pathway, etc.), TTD diseases (chronic inflammatory diseases, asthma, chronic obstructive pulmonary Disease, etc.), miRNA (MIR183), kinase (CDK7) and TF (LXR). QFPD contained 257 specific targets in addition to HCoV, pneumonia and ACE2 co-expression proteins. Then, network topology analysis of the five components-target-pathway-disease networks yielde"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T6","span":{"begin":79,"end":100},"obj":"Disease"},{"id":"T7","span":{"begin":102,"end":108},"obj":"Disease"},{"id":"T8","span":{"begin":110,"end":147},"obj":"Disease"},{"id":"T9","span":{"begin":257,"end":266},"obj":"Disease"}],"attributes":[{"id":"A6","pred":"mondo_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/MONDO_0021166"},{"id":"A7","pred":"mondo_id","subj":"T7","obj":"http://purl.obolibrary.org/obo/MONDO_0004979"},{"id":"A8","pred":"mondo_id","subj":"T8","obj":"http://purl.obolibrary.org/obo/MONDO_0005002"},{"id":"A9","pred":"mondo_id","subj":"T9","obj":"http://purl.obolibrary.org/obo/MONDO_0005249"}],"text":"gnaling pathway, adipocytokine signaling pathway, etc.), TTD diseases (chronic inflammatory diseases, asthma, chronic obstructive pulmonary Disease, etc.), miRNA (MIR183), kinase (CDK7) and TF (LXR). QFPD contained 257 specific targets in addition to HCoV, pneumonia and ACE2 co-expression proteins. Then, network topology analysis of the five components-target-pathway-disease networks yielde"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T8","span":{"begin":31,"end":40},"obj":"http://purl.obolibrary.org/obo/SO_0000418"}],"text":"gnaling pathway, adipocytokine signaling pathway, etc.), TTD diseases (chronic inflammatory diseases, asthma, chronic obstructive pulmonary Disease, etc.), miRNA (MIR183), kinase (CDK7) and TF (LXR). QFPD contained 257 specific targets in addition to HCoV, pneumonia and ACE2 co-expression proteins. Then, network topology analysis of the five components-target-pathway-disease networks yielde"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T4","span":{"begin":57,"end":60},"obj":"Chemical"},{"id":"T5","span":{"begin":190,"end":192},"obj":"Chemical"},{"id":"T6","span":{"begin":290,"end":298},"obj":"Chemical"}],"attributes":[{"id":"A4","pred":"chebi_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/CHEBI_73659"},{"id":"A5","pred":"chebi_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/CHEBI_74862"},{"id":"A6","pred":"chebi_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"}],"text":"gnaling pathway, adipocytokine signaling pathway, etc.), TTD diseases (chronic inflammatory diseases, asthma, chronic obstructive pulmonary Disease, etc.), miRNA (MIR183), kinase (CDK7) and TF (LXR). QFPD contained 257 specific targets in addition to HCoV, pneumonia and ACE2 co-expression proteins. Then, network topology analysis of the five components-target-pathway-disease networks yielde"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T1","span":{"begin":102,"end":108},"obj":"Phenotype"},{"id":"T2","span":{"begin":110,"end":147},"obj":"Phenotype"},{"id":"T3","span":{"begin":257,"end":266},"obj":"Phenotype"}],"attributes":[{"id":"A1","pred":"hp_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/HP_0002099"},{"id":"A2","pred":"hp_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/HP_0006510"},{"id":"A3","pred":"hp_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/HP_0002090"}],"text":"gnaling pathway, adipocytokine signaling pathway, etc.), TTD diseases (chronic inflammatory diseases, asthma, chronic obstructive pulmonary Disease, etc.), miRNA (MIR183), kinase (CDK7) and TF (LXR). QFPD contained 257 specific targets in addition to HCoV, pneumonia and ACE2 co-expression proteins. Then, network topology analysis of the five components-target-pathway-disease networks yielde"}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T10","span":{"begin":17,"end":48},"obj":"http://purl.obolibrary.org/obo/GO_0033211"},{"id":"T11","span":{"begin":17,"end":48},"obj":"http://purl.obolibrary.org/obo/GO_0033210"},{"id":"T12","span":{"begin":17,"end":48},"obj":"http://purl.obolibrary.org/obo/GO_0033209"},{"id":"T13","span":{"begin":31,"end":48},"obj":"http://purl.obolibrary.org/obo/GO_0007165"},{"id":"T14","span":{"begin":31,"end":40},"obj":"http://purl.obolibrary.org/obo/GO_0023052"},{"id":"T15","span":{"begin":190,"end":192},"obj":"http://purl.obolibrary.org/obo/GO_0000981"}],"text":"gnaling pathway, adipocytokine signaling pathway, etc.), TTD diseases (chronic inflammatory diseases, asthma, chronic obstructive pulmonary Disease, etc.), miRNA (MIR183), kinase (CDK7) and TF (LXR). QFPD contained 257 specific targets in addition to HCoV, pneumonia and ACE2 co-expression proteins. Then, network topology analysis of the five components-target-pathway-disease networks yielde"}

{"project":"LitCovid-sentences","denotations":[{"id":"T13","span":{"begin":200,"end":299},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"gnaling pathway, adipocytokine signaling pathway, etc.), TTD diseases (chronic inflammatory diseases, asthma, chronic obstructive pulmonary Disease, etc.), miRNA (MIR183), kinase (CDK7) and TF (LXR). QFPD contained 257 specific targets in addition to HCoV, pneumonia and ACE2 co-expression proteins. Then, network topology analysis of the five components-target-pathway-disease networks yielde"}